Effects of alpha lipoic acid as a supplement for weight loss in obese children and adolescents.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

PACTR

Registry ID

PACTR201902612226918

Enrollment

Registered

2019-02-21

Start date

2018-05-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Paediatrics

Interventions

Alpha lipoic acid

placebo

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: obese healthy children of 10 years or more of age, the criterion for obesity was body mass index (BMI) greater than the 95th percentile for age and sex

Exclusion criteria

Exclusion criteria: diabetes mellitus, liver, renal, thyroid, inflammatory disease, and the use of any medication that may interfere with glucose or lipid metabolism as corticosteroids

Design outcomes

Primary

Measure	Time frame
weight and body mass index	—

Secondary

Measure	Time frame
Fasting blood glucose, lipid profiles including triglycerides , total cholesterol, high-density lipoprotein cholesterol, Low-density lipoprotein cholesterol, Serum malondialdhyde, serum leptin , serum adiponectin, Serum TNF-a.	—

Countries

Egypt

Contacts

Public ContactMohamed Elkashlan

assistant professor of anaesthesiology

mohamedkashlan@yahoo.com00201222337746

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026